| Prev Close | 131.27 |
| Open | 131.03 |
| Day Low/High | 130.14 / 131.36 |
| 52 Wk Low/High | 121.00 / 148.99 |
| Volume | 4.19M |
| Avg Volume | 7.65M |
Johnson & Johnson (JNJ)
131.00
0.27
0.21
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 2.63B |
| Market Cap | 345.70B |
| EPS | 5.70 |
| P/E Ratio | 25.02 |
| Div & Yield | 3.80 (2.80%) |
Cramer: The Right Stocks Rallied Today
Merger news, healthcare gains, industrials and even airlines joined the party.
Johnson & Johnson Poised to Move Higher, Buy Available Weakness
With JNJ now set to close above $134, another look is in order.
Jim Cramer: You Have to Decide If You Want to Profit From This Moment
We have a different kind of market where you must know the SYMBOLS and know what the companies do that are the symbols.
Jim Cramer: Drug Stocks on the Move
We could be poised for even a further advance PROVIDED that we stay oversold.
The Decline In Johnson & Johnson Could Be Close to Being Over
How do the charts look now and is it safe to consider being a buyer again?
Jim Cramer: These 4 Stocks Seem Attractive Right Here
There is nothing wrong with Intel, Johnson & Johnson, 3M and Apple.
Cramer: This Is a Market Reset
We are in a good-is-now-bad world.
Caution Flag Is Out on Johnson & Johnson's Stock
With JPMorgan, Berkshire Hathaway and Amazon disrupting the health care space this morning a fresh look at JNJ is in order.
Dollar Decimation Creates Buy Opportunity
The time is right to buy this consumer products giant.
Cramer: Time to Throw Out The Old Rules
Stocks don't react to bad news the way they used to.
President Trump's Trade War Begins
It's no secret that President Trump abhors trade deficits.
Jim Cramer: The 3 Best Sectors That Lifted the Stock Market
It's hard to understand the magnitude of the change.
No More Tears: Johnson & Johnson Is Still in an Uptrend and Keeping Me Humble
Our latest update on how to trade JNJ.
CVS Bans Photo Manipulation on Beauty Products, What You Need to Know
CVS bans photoshopping photos on its beauty products. Could it have a ripple effect for its suppliers like Procter & Gamble? Watch the video to learn more.
Jim Cramer: I Blame the Pajama Traders for This Selloff
They make more irrational, stupid moves based on nothing than I ever thought possible.
Cramer: 5 Rules for Our Beast of a Bull Market
It might look easy now, but it looked easy in 1999, too.
Cramer: Lessons From the Market and ICR
You can make a case to buy any of the stocks of the companies at ICR.
Novice Trade: Pfizer
The trade for highly discretionary capital is the in-the-money, long call shooter expiring in January.
Cramer: 'Am I Diversified?' May Be Boring, but It Can Help Avoid the Pain
And on days like today, there can be a lot of it for some investors.
Johnson & Johnson Is One of 3 Big Names to Put on Your Weak Dollar Shopping List
Which stocks stand to benefit from an ailing dollar for the rest of 2017 and beyond?
Weak Dollar Makes These 3 Stocks Must Owns
Which stocks stand to benefit from an ailing dollar for the rest of 2017 and beyond?
Microsoft Is 1 of 3 Stocks Set to Break Out
All three have clear risk definitions.
Applied Materials Headed Higher in Long Term
Applied Materials is still in a bullish trend, though it may trade sideways for a while.
Notable Movements
In terms of sector price movement today: * FANGs continue to extend recent gains. * Retail has picked up a bid late in the day. Walmart Dillard's and Foot Locker are upside features. * Big Pharma stronger -- led by Merck ,Bristol-Myers Squibb , Lil...
Geron Shares Rise on Fast Track Designation -- Biotech Movers
The FDA granted fast track designation to imetelstat as a potential treatment for adults with with transfusion-dependent anemia.
Cramer: How We Got Into This Rotation
Everything's set up to compound it, and that's just what's happening.
Eli Lilly Had a Good Quarter but Investors Don't Want Health Stocks: Jim Cramer
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer said Eli Lilly LLY had a good quarter but the stock is getting hit by a rotation, as opposed to its specific performance.
My Takeaways and Observations
There's something happening here What it is ain't exactly clear There's a man with a gun over there Telling me I got to beware -- Buffalo Springfield, For What Its Worth Few longs meet my standards and I now believe risk exceeds reward (S&P kind) by...
Cramer: How to Find the Open Receiver in a Pullback
You've got to run the stock checkdown.
